KPC Pharmaceuticals Inc (600422) — Cash Flow Reinvestment Rate
KPC Pharmaceuticals Inc (600422) has a Cash Flow Reinvestment Rate of 0.89x as of June 2025, reinvesting CN¥318.54 Million (capex CN¥13.08 Million plus investments CN¥-305.46 Million) from operating cash flow of CN¥358.28 Million. Check 600422 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
KPC Pharmaceuticals Inc Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for KPC Pharmaceuticals Inc across 24 annual periods. Explore 600422 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for KPC Pharmaceuticals Inc (1999–2024)
Year-by-year capital reinvestment analysis for KPC Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of KPC Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥244.84 Million | CN¥808.07 Million | CN¥79.43 Million | ▼ -73.3% |
| 2023 | 1.14x | CN¥404.70 Million | CN¥356.08 Million | CN¥65.48 Million | ▼ -14.2% |
| 2022 | 1.32x | CN¥336.35 Million | CN¥253.90 Million | CN¥101.75 Million | ▼ -25.1% |
| 2021 | 1.77x | CN¥444.88 Million | CN¥251.63 Million | CN¥236.17 Million | ▲ +219.0% |
| 2020 | 0.55x | CN¥227.19 Million | CN¥409.94 Million | CN¥158.73 Million | ▼ -56.1% |
| 2019 | 1.26x | CN¥541.78 Million | CN¥429.50 Million | CN¥347.35 Million | ▼ -32.1% |
| 2018 | 1.86x | CN¥654.55 Million | CN¥352.07 Million | CN¥217.26 Million | ▲ +40.2% |
| 2017 | 1.33x | CN¥321.69 Million | CN¥242.53 Million | CN¥268.74 Million | ▲ +75.0% |
| 2016 | 0.76x | CN¥235.78 Million | CN¥311.16 Million | CN¥203.45 Million | ▼ -77.4% |
| 2015 | 3.35x | CN¥1.60 Billion | CN¥476.62 Million | CN¥210.82 Million | ▲ +469.8% |
| 2014 | 0.59x | CN¥222.98 Million | CN¥379.13 Million | CN¥222.98 Million | ▼ -33.1% |
| 2013 | 0.88x | CN¥212.65 Million | CN¥241.97 Million | CN¥212.65 Million | ▲ +52.2% |
| 2012 | 0.58x | CN¥123.22 Million | CN¥213.33 Million | CN¥123.22 Million | ▲ +89.0% |
| 2011 | 0.31x | CN¥42.85 Million | CN¥140.24 Million | CN¥42.85 Million | ▼ -56.7% |
| 2010 | 0.71x | CN¥64.16 Million | CN¥90.82 Million | CN¥64.16 Million | ▲ +382.6% |
| 2009 | 0.15x | CN¥18.82 Million | CN¥128.57 Million | CN¥18.82 Million | ▲ +2.4% |
| 2008 | 0.14x | CN¥13.09 Million | CN¥91.59 Million | CN¥13.09 Million | ▲ +11.5% |
| 2007 | 0.13x | CN¥16.67 Million | CN¥130.06 Million | CN¥16.67 Million | ▼ -73.0% |
| 2006 | 0.47x | CN¥29.03 Million | CN¥61.25 Million | CN¥29.03 Million | ▼ -9.5% |
| 2003 | 0.52x | CN¥32.08 Million | CN¥61.23 Million | CN¥32.08 Million | ▼ -88.6% |
| 2002 | 4.58x | CN¥79.62 Million | CN¥17.38 Million | CN¥79.62 Million | ▲ +1594.6% |
| 2001 | 0.27x | CN¥18.13 Million | CN¥67.07 Million | CN¥18.13 Million | ▼ -46.7% |
| 2000 | 0.51x | CN¥24.20 Million | CN¥47.76 Million | CN¥24.20 Million | ▲ +141.1% |
| 1999 | 0.21x | CN¥12.67 Million | CN¥60.24 Million | CN¥12.67 Million | — |